SAMANTHA BEIL: Open Payments
NPI 1659396059 · COMMACK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$483 in 20 payments from 10 companies in 2025. Trend: 2023 $352 · 2024 $514 · 2025 $483
Food & beverage: $483
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $151 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $105 |
| Novo Nordisk Inc | 3 | $60 |
| Lilly USA, LLC | 2 | $41 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Alexion Pharmaceuticals, Inc. | 1 | $18 |
| Abbott Laboratories | 1 | $16 |
Products named: AIRSUPRA, Ozempic, JARDIANCE, MOUNJARO, NEXLETOL, GARDASIL 9, RECORLEV, MYFEMBREE.
Industry payments across NY — which companies pay providers there.
